Colon cancer cases are on the rise in those under 50 Published on 30/03/2022 Various scientific studies confirm an increased incidence rate of colon cancer in young adults. In Europe, specifically, between 40 and 45 years old, one study observed an annual increase of 1.6% between 2004 and 2016
MD Anderson Madrid – Hospiten performs two simultaneous liver and rectal surgeries on the same patient with the Da Vinci robot Published on 22/03/2022 Thanks to the versatility of the Da Vinci robot, a minimally invasive approach can be performed to radically remove tumors correctly through fine dissections, thus accelerating patient recovery
Immediate access to innovation in kidney cancer treatments, essential for patient survival Published on 08/03/2022 MD Anderson Madrid – Hospiten offers the possibility of access to clinical trials and surgery with the Da Vinci robot for patients with kidney cancer, one of the 15 most common tumors in Spain
A multidisciplinary approach is key to the treatment of the more than one hundred types of sarcomas we deal with Published on 01/03/2022 All medical specialties may be involved in this disease, among the most common are Traumatology, Medical Oncology, Radiotherapy Oncology, Anatomic and Molecular Pathology, Radiodiagnosis, Rehabilitation and Plastic Surgery.
The DIPCAN study seeks to change the way metastatic cancer is treated in Spain thanks to the integration of clinical, genomic, anatomic pathology and radiology image data from 2,000 patients Published on 22/02/2022 Participating patients will have free access to the genomic study of their tumor, both in the biopsy sample and in blood, to a full-body MRI and to digitization of anatomic pathology images
Artificial intelligence, liquid and genomic biopsy to personalize the treatment of endometrial cancer and improve the prognosis Published on 03/02/2022 MD Anderson Cancer Center Foundation Spain is participating in a project, with three other European countries, that will study tumors at a molecular level and seek to expand therapy options in the most advanced stages of endometrial cancer. The study will combine pre-clinical models and artificial intelligence solutions to generate an algorithm to predict the therapeutic response of patients. Endometrial cancer is the most common gynecological tumor in developed countries and the overall survival rate of patients is reduced from 90% to 17% if there is a late diagnosis1
I have cancer: How do I tell my children? Published on 03/02/2022 Normalization the use of the word 'cancer' may be key to achieving a generational change toward destigmatizing the disease, thus improving the quality of life of patients. Providing the child wishes to do so, sharing information with young children relieves the anxiety and uncertainty of the disease, and helps prevent them from seeking answers by other means. Involving children in the changes that our body will undergo, making them see the process as something natural will help us to have a healthier relationship with the unpleasant emotions that arise during the process.
Un 10% de los cánceres se puede prevenir gracias a los estudios genéticos Published on 18/01/2022 Los pacientes que hayan padecido más de un tipo de cáncer o aquellas personas cuya familia presente más casos de cáncer de lo estadísticamente razonable, son los principales candidatos para realizar un estudio genético
Recommendations for cancer patients and those close to them at a Christmas marked by the COVID-19 pandemic Published on 27/12/2021 For cancer patients, these days can be as rewarding as they are complicated and knowing how to manage their feelings is key to ensuring good emotional management
Dr. Natalia Carballo elected Ambassador of the city of Madrid by the City Council Tourist Office Published on 16/12/2021 The doctor has received this recognition thanks to her personal commitment and work campaigning for the 40th Meeting of the European Society for Radiotherapy & Oncology (ESTRO) to be held in Madrid in August, thus making the capital the European headquarters of Radiation Oncology.